Inventors:
Horea Rus - Catonsville MD, US
Cornelia Cudrici - Rockville MD, US
Cosmin Tegla - Baltimore MD, US
International Classification:
C12Q 1/68, G01N 33/567
Abstract:
The present invention provides a method for determining whether an individual with relapsing-remitting multiple sclerosis will suffer a relapse. In the method, measuring the level of Response Gene to Complement (RGC)-32 is measured in the individual, where a significantly lower level of RGC-32 therein indicates that the individual will have or is having a relapse of multiple sclerosis.